Adhd Clinical Trial
— Hyper-mCBTOfficial title:
Third Generation Cognitive Behavioural Therapy Versus Treatment-as-usual for Attention Deficit and Hyperactivity Disorder: a Randomized, 2-parallel-group, Evaluator Blinded, Superiority Trial
Verified date | January 2023 |
Source | Centre Hospitalier Universitaire de Nimes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The investigators hypothesize that the mindfulness Cognitive Behavioral Therapy program will lead to a reduction in attention deficit and hyperactivity disorder symptoms, anxiety and depression, and improve self-confidence, emotional control, social integration and school results.
Status | Completed |
Enrollment | 248 |
Est. completion date | November 23, 2022 |
Est. primary completion date | November 23, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 15 Years |
Eligibility | Inclusion Criteria: - If deemed able, the patient must have given his/her informed and signed consent - The parents (or legal guardian) of minor patients must have given their informed and signed consent. - The patient and participating parents must be insured or beneficiary of a health insurance plan - The patient is equal to or greater than 7 years old and less than or equal to 15 years old - The patient presents with attention deficit and hyperactivity disorder with an ADHDRS-PI score > 27 - The patient is currently not under treatment - OR - is treated with methylphenidate with a stable posology (not expected to vary in the near future) but remains symptomatic Exclusion Criteria: - The patient is participating in, or has participated in over the past three months, another trial or another study that may interfere with the results or conclusion of the present study - The patient is in an exclusion period determined by a previous study - The participating parent(s) is(are) under judicial protection, or is an adult under guardianship - It is impossible to correctly inform the patient or his/her parent or legal guardian - Patients or parents refusing participation, signature of the signed consent or follow-up procedures - Previously documented mental retardation (IQ < 70) or suspicion thereof by the investigator - The patient has already participated in cognitive behavioural therapy (individual or group) in the six months preceding inclusion - Patients diagnosed with autism spectrum disorder, psychotic disorder or bipolar disorder - The family has participated in a parental guidance programme in the last 6 months. - The family has already participated in the present study |
Country | Name | City | State |
---|---|---|---|
France | CHU Montpellier | Montpellier | |
France | CHU Nimes | Nîmes | |
France | APHP - Hôpital Robert Debré | Paris | |
France | Chu de Strasbourg | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ADHD symptom severity | clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54 | baseline | |
Primary | ADHD symptom severity | clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54 | Month 5 | |
Primary | ADHD symptom severity | clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54 | Month 8 | |
Secondary | Parenting styles | Parental Authority Questionnaire (PAQ); 30 items per parent | Baseline | |
Secondary | Parenting styles | Parental Authority Questionnaire (PAQ); 30 items per parent | Month 5 | |
Secondary | Parenting styles | Parental Authority Questionnaire (PAQ); 30 items per parent | Month 8 | |
Secondary | The quality of life for parents. | Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85 | Baseline | |
Secondary | The quality of life for parents. | Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85 | Month 5 | |
Secondary | The quality of life for parents. | Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85 | Month 8 | |
Secondary | Global function | Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7 | Baseline | |
Secondary | Global function | Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7 | Month 5 | |
Secondary | Global function | Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7 | Month 8 | |
Secondary | Global function | Children's Global Assessment Scale CGAS) questionnaire; score ranges from 0-100 | Baseline | |
Secondary | Global function | Children's Global Assessment Scale CGAS) questionnaire; score ranges from 0-100 | Month 5 | |
Secondary | Global function | Children's Global Assessment Scale CGAS) questionnaire; score ranges from 0-100 | Month 8 | |
Secondary | Social well-being and school parameters for children | CONNERS for school teachers; cut-off for significant behavioral problem >15 his questionnaire will be given to the first patients included to 149 th patient included | Baseline | |
Secondary | Social well-being and school parameters for children | SDQ ; cut-off for significant behavioral problem >15 . his questionnaire will be given to the first patients included to 149 th patient included his questionnaire will be given to 150th patients included to 248th patient included | Baseline | |
Secondary | Social well-being and school parameters for children | SDQ ; cut-off for significant behavioral problem >15 . his questionnaire will be given to the first patients included to 149 th patient included his questionnaire will be given to 150th patients included to 248th patient included | Month 5 | |
Secondary | Social well-being and school parameters for children | CONNERS for school teachers; cut-off for significant behavioral problem >15 his questionnaire will be given to the first patients included to 149 th patient included | Month 8 | |
Secondary | Anxiety in children | Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale | Baseline | |
Secondary | Anxiety in children | Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale | Month 5 | |
Secondary | Anxiety in children | Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale | Month 8 | |
Secondary | Depression in children | Children depression inventory (CDI) questionnaire; score ranges from 0-54 | Baseline | |
Secondary | Depression in children | Children depression inventory (CDI) questionnaire; score ranges from 0-54 | Month 5 | |
Secondary | Depression in children | Children depression inventory (CDI) questionnaire; score ranges from 0-54 | Month 8 | |
Secondary | Anxiety and depression in parents | Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21 | Baseline | |
Secondary | Anxiety and depression in parents | Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21 | Month 5 | |
Secondary | Anxiety and depression in parents | Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21 | Month 8 | |
Secondary | Self-Esteem and behaviour for children. | Rosenberg scale; score ranges from 0-40 | Baseline | |
Secondary | Self-Esteem and behaviour for children. | Rosenberg scale; score ranges from 0-40 | Month 5 | |
Secondary | Self-Esteem and behaviour for children. | Rosenberg scale; score ranges from 0-40 | Month 8 | |
Secondary | Self-Esteem and behaviour for children. | CONNERS questionnaire for parents; cut-off for significant behavioral problem >15 | Baseline | |
Secondary | Self-Esteem and behaviour for children. | CONNERS questionnaire for parents; cut-off for significant behavioral problem >15 | Month 5 | |
Secondary | Self-Esteem and behaviour for children. | CONNERS questionnaire for parents; cut-off for significant behavioral problem >15 | Month 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Recruiting |
NCT06038942 -
Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress
|
N/A | |
Not yet recruiting |
NCT06456372 -
Digital Health Intervention for Children With ADHD
|
N/A | |
Completed |
NCT05518435 -
Managing Young People With ADHD in Primary Care Study
|
||
Active, not recruiting |
NCT04978792 -
Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD?
|
N/A | |
Completed |
NCT03216512 -
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD
|
N/A | |
Completed |
NCT02829528 -
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Not yet recruiting |
NCT02906501 -
Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
|
N/A | |
Terminated |
NCT02271880 -
Improving Medication Adherence in ADHD Adolescents
|
N/A | |
Completed |
NCT02562469 -
ACTIVATE: A Computerized Training Program for Children With ADHD
|
N/A | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02463396 -
Mindfulness Training in Adults With ADHD
|
N/A | |
Completed |
NCT01673594 -
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
|
Phase 4 | |
Terminated |
NCT01733680 -
Amiloride Hydrochloride as an Effective Treatment for ADHD
|
Early Phase 1 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Active, not recruiting |
NCT01137318 -
Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 2 | |
Completed |
NCT01404273 -
Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder
|
N/A | |
Completed |
NCT00586157 -
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
|
Phase 4 | |
Completed |
NCT00573859 -
The Reinforcing Mechanisms of Smoking in Adult ADHD
|
Phase 1/Phase 2 |